-
| Exchange | NASDAQ |
|---|---|
| CurrencyCode | USD |
| ISIN | US45175G2075 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Target Price | 30 |
|---|---|
| PE Ratio | None |
| Market Cap | 92M |
| Beta | nan |
| Dividend Yield | None |
ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for IMA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026